Trial Profile
Impact of Nebivolol on Central Aortic Pressure.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2011
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 29 Jul 2011 Planned end date changed from 1 May 2012 to 1 May 2010 as reported by ClinicalTrials.gov.
- 29 Jul 2011 Primary endpoint identified as reported by ClinicalTrials.gov.
- 16 Aug 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.